EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms

Tadashi Toyohara iD, Michihiro Yoshida iD, Katsuyuki Miyabe iD, Kazuki Hayashi, Itaru Naitoh, Hiromu Kondo, Yasuki Hori, Akihisa Kato iD, Kenta Kachi, Go Asano, Hidenori Sahashi, Akihisa Adachi und 4 weitere

Cancer Science · 2023

DOI: 10.1111/cas.15980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Tadashi Toyohara und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Pancreas Research Foundation of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic neuroendocrine neoplasms (panNENs) are rare pancreatic neoplasms, and descriptions of treatment remain limited. Autotaxin (ATX) is a secreted autocrine motility factor involved in the production of lysophosphatidic acid (LPA), a lipid mediator that promotes the progression of various cancers. The aim of this study was to clarify the importance of the ATX‐LPA axis in panNENs and to confirm its contribution to panNEN progression using clinical data, cell lines, and a mouse model. Serum ATX level was higher in patients with panNEN than in patients with other pancreatic diseases (chronic pancreatitis, pancreatic ductal adenocarcinoma [PDAC], intraductal papillary mucinous neoplasm, autoimmune pancreatitis) and healthy controls, and 61% of clinical specimens stained strongly for ATX. In a case we encountered, serum ATX level fluctuated with disease progression. An in vitro study showed higher ATX mRNA expression in panNEN cell lines than in PDAC cell lines. Cell proliferation and migration in panNEN cell lines were stimulated via the ATX‐LPA axis and suppressed by RNA interference or inhibitors. An in vivo study showed that intraperitoneal injection of GLPG1690, an ATX inhibitor, suppressed tumor progression in a xenograft model. These findings revealed that ATX expression is significantly elevated in panNEN and is related to the progression of panNEN. We showed the potential of ATX as a novel biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsPancreatic NeoplasmsAnimalsHumansMiceBiomarkersCell LineDisease Models, AnimalPhosphoric Diester HydrolasesRNA InterferenceLysophospholipase D

Stichwörter der Autor:innen

autotaxinbiomarkerlysophosphatidic acidmolecular target therapyneuroendocrine tumor

Substanzen

BiomarkersPhosphoric Diester HydrolasesLysophospholipase D

Autor:innen und Institutionen

  • Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Gastroenterology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
  • Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

ORCID-Profile: Tadashi Toyohara, Michihiro Yoshida, Katsuyuki Miyabe, Akihisa Kato, Yoichi Matsuo, Hiromi Kataoka

Förderung

  • Japan Society for the Promotion of Science
  • Pancreas Research Foundation of Japan

Zitieren

APA

Toyohara, T., Yoshida, M., Miyabe, K., Hayashi, K., Naitoh, I., Kondo, H., Hori, Y., Kato, A., Kachi, K., Asano, G., Sahashi, H., Adachi, A., Kuno, K., Kito, Y., Matsuo, Y., & Kataoka, H. (2023). Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms. Cancer Science. https://doi.org/10.1111/cas.15980

Vancouver

Toyohara T, Yoshida M, Miyabe K, Hayashi K, Naitoh I, Kondo H, et al. Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms. Cancer Science. 2023. doi:10.1111/cas.15980

BibTeX
@article{Toyohara2023,
  author = {Toyohara, Tadashi and Yoshida, Michihiro and Miyabe, Katsuyuki and Hayashi, Kazuki and Naitoh, Itaru and Kondo, Hiromu and Hori, Yasuki and Kato, Akihisa and Kachi, Kenta and Asano, Go and Sahashi, Hidenori and Adachi, Akihisa and Kuno, Kayoko and Kito, Yusuke and Matsuo, Yoichi and Kataoka, Hiromi},
  title = {Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15980}
}
Kostenlos starten →